We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Yield10 Bioscience Inc (YTEN) USD0.01

Sell:$1.07 Buy:$1.07 Change: $0.31 (41.05%)
Market closed |  Prices as at close on 7 October 2024 | Switch to live prices |
Sell:$1.07
Buy:$1.07
Change: $0.31 (41.05%)
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Deal now
Market closed |  Prices as at close on 7 October 2024 | Switch to live prices |
Sell:$1.07
Buy:$1.07
Change: $0.31 (41.05%)
Market closed |  Prices as at close on 7 October 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and PHA bioplastics for use as biodegradable bioplastics. The Company is pursuing Camelina seed oil products for two market opportunities and value chains. The first product is seed oil produced by Camelina, which is genetically engineered to enable production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). The second product is Camelina seed oil for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD) and sustainable aviation fuel (SAF).

Contact details

Address:
19 Presidential Way
WOBURN
01801
United States
Telephone:
+1 (617) 5831700
Website:
https://www.yield10bio.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
YTEN
ISIN:
US98585K8541
Market cap:
$499,440
Shares in issue:
657,160
Sector:
Biotechnology
Exchange:
Off Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Oliver Peoples
    President, Chief Executive Officer, Director
  • Charles Haaser
    Chief Accounting Officer, Vice President - Finance, Treasurer
  • Kristi Snell
    Vice President - Research, Chief Science Officer
  • Lynne Brum
    Vice President - Planning and Corporate Communications, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.